OptimizeRx Corporation (OPRX)

OptimizeRx Revenue

OptimizeRx had revenue of $78.21M in the twelve months ending March 31, 2024, with 26.71% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $19.69M with 51.43% year-over-year growth. In the year 2023, OptimizeRx had annual revenue of $71.52M with 14.53% growth.

• Revenue (ttm): $78.21M
• Revenue Growth: +26.71%
• P/S Ratio: 2.35
• Revenue / Employee: $579,323
• Employees: 135
• Market Cap: 183.98M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	71.52M	9.07M	14.53%
Dec 31, 2022	62.45M	1.16M	1.89%
Dec 31, 2021	61.29M	17.98M	41.51%
Dec 31, 2020	43.31M	18.72M	76.08%
Dec 31, 2019	24.60M	3.39M	15.99%
Dec 31, 2018	21.21M	9.08M	74.86%
Dec 31, 2017	12.13M	4.38M	56.45%
Dec 31, 2016	7.75M	530.78K	7.35%
Dec 31, 2015	7.22M	717.72K	11.04%
Dec 31, 2014	6.50M	1.82M	38.96%
Dec 31, 2013	4.68M	2.69M	135.27%
Dec 31, 2012	1.99M	877.57K	78.95%
Dec 31, 2011	1.11M	1.04M	1,464.09%
Dec 31, 2010	71.07K	44.34K	165.93%
Dec 31, 2009	26.72K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.